Larvol Delta - Headtohead-comparison-of-inclisiran-vs-bempedoic-acid-for-LDL-C-lowering-in-patients-with-high-and-very-high-cardiovascular-risk-Results-from-the-phase-4-VICTORIONCHALLENGE-trial

Leqvio (inclisiran) - Novartis

Nexletol (bempedoic acid) - Esperion Therap, CSL Behring

https://digital-congress.escardio.org/ESC-Congress/Sessions/21836

Ingo Hilgendorf

Jul 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next